Market research
7707.TSE Precision System Science Co., Ltd
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 6B
- P/E ratio
- 14.15
- Analyst target
- Not available
- Dividend yield
- 1.0%
- Beta
- 0.67
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- JP3833400009
- Market cap
- 6B
- P/E ratio
- 14.15
- Analyst target
- Not available
- Dividend yield
- 1.0%
- Beta
- 0.67
About
About Precision System Science Co., Ltd
Precision System Science Co., Ltd., together with its subsidiaries, engages in the development, manufacturing, and sale of automated systems/instruments, other physicochemical instruments, software, and other products in Japan. It also offers geneLEAD series; extraction reagents for nucleic acid extraction and biochemical testing; and LecChip series products. In addition, the company manufactures and sells reagents, as well as plastic consumables for use in the automated system/instruments. Its products are used in research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was incorporated in 1985 and is headquartered in Matsudo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 7707.TSE discussion.
5 years, 5 months ago
Precision System Science Co., Ltd is currently in a long term downtrend where the price is trading 20.2% below its 200 day moving average.
From a valuation standpoint, the stock is 94.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Precision System Science Co., Ltd's total revenue rose by 121.3% to $2B since the same quarter in the previous year.
Its net income has increased by 269.9% to $159M since the same quarter in the previous year.
Based on the above factors, Precision System Science Co., Ltd gets an overall score of 3/5.